India progressing well in radio pharmaceuticals, says former IAEA Director

‘Advancements in nuclear diagnostic imaging have led to significant ease in the diagnosis of chronic disorders’

March 01, 2021 06:33 pm | Updated 06:33 pm IST - VISAKHAPATNAM

Nuclear medicine has witnessed a number of technological advances with its applications ranging from diagnostics to therapeutics and India is progressing well in radio pharmaceuticals, former Director of the International Atomic Energy Agency (IAEA) Meera Venkatesh has said.

Participating as the chief guest at the valedictory of the National Science Week celebrations at GITAM Deemed to be University here on Monday, Dr. Meera, who is also former former Director of BARC Radio Pharmaceuticals Division, said that after establishing BARC-Dhruva research reactor several radionuclides were produced for healthcare. The establishment of 20 Med cyclotrons and 350 Nuclear Medicine Centres and innumerable X ray and CT centres shows how the country was using nuclear medicine in the healthcare sector.

She said that several technological advancements in nuclear diagnostic imaging have led to significant ease in the diagnosis, treatment and management of chronic and critical disorders. She also briefed about the use of radiation to treat cancer and in cardiology.

GITAM Deemed to be University Vice-Chancellor K. Sivaramakrishna said that when young people contribute their ideas and energy to addressing social issues, they begin to see themselves as capable leaders who can make significant contribution to the lives of others. Youth, who might otherwise feel academically or socially inferior to their peers, should realise that their unique strengths would be needed to build a better world, he added.

GITAM Vice-Chancellor N. Siva Prasad and Science Dean A. Subrahmanyam were among those who participated in the programme.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.